ESR1 Mutations Affect Anti-proliferative Responses to Tamoxifen through Enhanced Cross-Talk with IGF Signaling

It is now generally accepted that estrogen receptor (ESR1) mutations occur frequently in metastatic breast cancers, however we do not yet know how to best treat these patients. We have modeled the three most frequent hormone binding ESR1 (HBD-ESR1) mutations (Y537N, Y537S, and D538G) using stable le...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Breast Cancer Res Treat
Main Authors: Gelsomino, Luca, Gu, Guowei, Rechoum, Yassine, Beyer, Amanda R, Pejerrey, Sasha M, Tsimelzon, Anna, Wang, Tao, Huffman, Kenneth, Ludlow, Andrew, Ando’, Sebastiano, Fuqua, Suzanne AW
Format: Artigo
Sprog:Inglês
Udgivet: 2016
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5510243/
https://ncbi.nlm.nih.gov/pubmed/27178332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3829-5
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker